Mod­er­na's Phase 3 flu vac­cine ef­fi­ca­cy in line with com­peti­tors, tee­ing up new sub­mis­sions

Mod­er­na said Mon­day that its flu vac­cine was 26.6% ef­fec­tive at pre­vent­ing ill­ness com­pared to a li­censed com­para­tor — a sim­i­lar show­ing to oth­er up­dat­ed shots …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER